Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCUS

Arcus Biosciences Inc

Jun 18 • 04:00PM ET

24.31

+0.19 0.79 %

Healthcare • Biotechnology • USA • Mid • NYSE

Peers: CGON ERAS TNGX KYMR NUVL AXSM BMRN INCY RYTM KRYS

| Held by: IJR VTI XBI IWM VB VXF SPSM VBK IBB IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.18	Insider Own	33.46%	Shs Outstand	125.50M	Perf Week	4.33%
Market Cap	3.06B	Forward P/E	-	EPS next Y	-3.44	Insider Trans	-0.12%	Shs Float	83.50M	Perf Month	6.86%
Enterprise Value	2.35B	PEG	-	EPS next Q	-0.89	Inst Own	66.50%	Short Float	14.02%	Perf Quarter	8.38%
Income	-369.00M	P/S	12.96	EPS this Y	-11.81%	Inst Trans	-2.32%	Short Ratio	10.07	Perf Half Y	9.50%
Sales	236.00M	P/B	5.82	EPS next Y	6.39%	ROA	-34.28%	Short Interest	11.71M	Perf YTD	2.01%
Book/sh	4.18	P/C	3.72	EPS next 5Y	11.07%	ROE	-69.95%	52W High	28.72 -15.36%	Perf Year	185.66%
Cash/sh	6.54	P/FCF	-	EPS past 3/5Y	3.94% -7.95%	ROIC	-59.13%	52W Low	7.91 207.33%	Perf 3Y	24.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.16% 26.08%	Gross Margin	96.19%	Volatility	4.25% 5.92%	Perf 5Y	5.42%
Dividend TTM	-	EV/Sales	9.95	EPS Y/Y TTM	24.05%	Oper. Margin	-168.64%	ATR (14)	1.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.04	Sales Y/Y TTM	67.38%	Profit Margin	-156.36%	RSI (14)	52.06	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	10.32%	SMA20	1.41%	Beta	0.85	Target Price	36.73
Payout	-	Debt/Eq	0.22	Sales Q/Q	-39.29%	SMA50	0.19%	Rel Volume	1.99	Prev Close	24.12
Employees	601	LT Debt/Eq	0.19	Earnings	May 05 AMC	SMA200	16.02%	Avg Volume	1.16M	Price	24.31
IPO	Mar 15, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.88% -42.34%	Trades		Volume	2,308,886	Change	0.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)